Rentech Ltd company a biotech company, is expected to grow rapidly in the next three years and then have a level growth rate for the foreseeable future. The company expects free cash flows of $342.50 million, $512.30 million, and $750.00 million over the next three years, and thereafter its cash flows will grow at a steady rate of 8.00 per cent per annum. The company has no non-operating assets (NOA). If the appropriate WACC is 11.25 per cent, what is the enterprise value of this business